Huang Bing, Yan Hui, Li Yunyao, Zhou Qiping, Abudoureyimu Ayipali, Cao Guiqiu, Jiang Hong
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.
J Cardiovasc Dev Dis. 2023 Jun 29;10(7):279. doi: 10.3390/jcdd10070279.
Over the past two decades, the rapid evolution of transcatheter aortic valve replacement (TAVR) has revolutionized the management of severe aortic stenosis (AS) in the elderly. The prevalence of comorbidities in elderly AS patients presents a considerable challenge to the effectiveness and prognosis of patients after TAVR. In this article, we aim to summarize some of the clinical aspects of the current use of TAVR in elderly patients and attempt to highlight the challenges and issues that need further consideration.
在过去二十年中，经导管主动脉瓣置换术（TAVR）的迅速发展彻底改变了老年重度主动脉瓣狭窄（AS）的治疗方式。老年AS患者中合并症的流行对TAVR术后患者的疗效和预后构成了相当大的挑战。在本文中，我们旨在总结目前TAVR在老年患者中应用的一些临床情况，并试图强调需要进一步考虑的挑战和问题。
